Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Incidence Of Neurovascular Conditions
3.1.2. Demand For Minimally Invasive Procedures
3.1.3. Significance Of Neurological Diseases In Geriatric Population
3.1.4. Prevalence Of Underlying Disease Conditions
3.2. Key Restraints
3.2.1. Exorbitant Cost Of Neurovascular Devices
3.2.2. Lack Of Adequate Number Of Trained Neurosurgeons

4. Key Analytics
4.1. Impact Of Covid-19 On Neurovascular Devices Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entry
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape

5. Market By Product
5.1. Embolization Devices
5.2. Accessory Devices
5.3. Revascularization Devices
5.4. Thrombectomy Devices
5.5. Embolic Protection Devices

6. Market By Application
6.1. Aneurysm
6.2. Ischemic Stroke
6.3. Stenosis
6.4. Arteriovenous Malformation (Avm)
6.5. Other Applications

7. Geographical Analysis
7.1. Europe
7.1.1. Market Size & Estimates
7.1.2. Key Growth Enablers
7.1.3. Key Challenges
7.1.4. Key Players
7.1.5. Country Analysis
7.1.5.1. Germany
7.1.5.2. United Kingdom
7.1.5.3. France
7.1.5.4. Italy
7.1.5.5. Russia
7.1.5.6. Poland
7.1.5.7. Belgium
7.1.5.8. Rest Of Europe

8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships & Agreements
8.1.4. Business Expansions, Announcements & Divestitures
8.2. Company Profiles
8.2.1. Acandis Gmbh
8.2.2. Asahi Intecc
8.2.3. B Braun Melsungen Ag
8.2.4. Integer Holdings Corporation
8.2.5. Johnson & Johnson (Cerenovus)
8.2.6. Kaneka Corporation
8.2.7. Medtronic Inc
8.2.8. Memry Corporation
8.2.9. Microport Scientific Corporation
8.2.10. Penumbra Inc
8.2.11. Phenox Gmbh
8.2.12. Rapid Medical
8.2.13. Sensome
8.2.14. Stryker Corporation
8.2.15. Terumo Medical Corporation (Microvention Inc)



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Europe Neurovascular Devices Market, By Product, In 2020
Figure 6: Europe Neurovascular Devices Market, By Embolization Devices, 2021-2028 (In $ Million)
Figure 7: Europe Neurovascular Devices Market, By Accessory Devices, 2021-2028 (In $ Million)
Figure 8: Europe Neurovascular Devices Market, By Revascularization Devices, 2021-2028 (In $ Million)
Figure 9: Europe Neurovascular Devices Market, By Thrombectomy Devices, 2021-2028 (In $ Million)
Figure 10: Europe Neurovascular Devices Market, By Embolic Protection Devices, 2021-2028 (In $ Million)
Figure 11: Europe Neurovascular Devices Market, By Application, In 2020
Figure 12: Europe Neurovascular Devices Market, By Aneurysm, 2021-2028 (In $ Million)
Figure 13: Europe Neurovascular Devices Market, By Ischemic Stroke, 2021-2028 (In $ Million)
Figure 14: Europe Neurovascular Devices Market, By Stenosis, 2021-2028 (In $ Million)
Figure 15: Europe Neurovascular Devices Market, By Arteriovenous Malformation (Avm), 2021-2028 (In $ Million)
Figure 16: Europe Neurovascular Devices Market, By Other Applications, 2021-2028 (In $ Million)
Figure 17: Europe Neurovascular Devices Market, Country Outlook, 2020 & 2028 (In %)
Figure 18: Germany Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 19: United Kingdom Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 20: France Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 21: Italy Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 22: Russia Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 23: Poland Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 24: Belgium Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 25: Rest Of Europe Neurovascular Devices Market, 2021-2028 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - NEUROVASCULAR DEVICES
TABLE 2: EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: EUROPE NEUROVASCULAR DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: EUROPE NEUROVASCULAR DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: LEADING PLAYERS OPERATING IN THE EUROPE NEUROVASCULAR DEVICES MARKET
TABLE 9: LIST OF MERGERS & ACQUISITIONS
TABLE 10: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 11: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 12: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES